A novel pattern of lipoaccumulation in HIV-infected men [6]

JAMA

Volumn 296, Issue 7, 2006, Pages 766-768

  Palella, Frank J ^a   Chmiel, Joan S ^a   Riddler, Sharon A ^b   Calhoun, Bridget ^b   Dobs, Adrian ^c   Visscher, Barbara ^d   Kingsley, Lawrence ^e  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; COSMETIC; GLUCOSE; LIPID; PROTEINASE INHIBITOR;

ADULT; ANAMNESIS; ANTHROPOMETRY; BLOOD EXAMINATION; BODY HEIGHT; BODY MASS; BODY WEIGHT; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HEALTH PRACTITIONER; HETEROSEXUALITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; INFORMED CONSENT; LETTER; LIPID BLOOD LEVEL; LIPOATROPHY; LONGITUDINAL STUDY; MALE; MEDICAL ASSESSMENT; MULTICENTER STUDY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; SELF REPORT;

EID: 33747112051     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.296.7.766     Document Type: Letter

References (6)

1. Carr A, Emery S, Law M, et al. An objective case definition of lipodystrophy in HIV-infected adults: a case-control study. Lancet. 2003;361:726-735.
2. Palella FJ, Cole SR, Chmiel JS, et al. Anthropometrics and examiner reported body habitus changes in the Multicenter AIDS Cohort Study. Clin Infect Dis. 2004;38:903-907.
3. Gallant JE, Stasczewski S, Pozniak A, et al. Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial. JAMA. 2004;292:191-201.
4. Noor MA, Seneviratne T, Aweeka FT, et al. Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: a randomized, placebo-controlled study. AIDS. 2002;16:F1-F8.
5. Lee GA, Seneviratne T, Noor MA, et al. The metabolic effects of lopinavir/ritonavir in HIV-negative men. AIDS. 2004;18:641-649.
6. Lichtenstein KA, Delaney KM, Armon C, et al. Incidence of and risk factors for lipoatrophy (abnormal fat loss) in ambulatory HIV-1-infected patients. J Acquir Immune Defic Syndr. 2003;32:48-56.